Cationized albumin conjugated solid lipid nanoparticles as vectors for brain delivery of an anti-cancer drug

Current Nanoscience

Volumn 7, Issue 1, 2011, Pages 71-80

  Agarwal, Abhinav ^a   Majumder, Saikat ^b   Agrawal, Himanshu ^c   Majumdar, Subrata ^b   Agrawal, Govind P ^a  

^a DR H S GOUR UNIVERSITY   (India)

^b BOSE INSTITUTE   (India)

^c M S UNIVERSITY OF BARODA   (India)

Author keywords

Brain; Cationic bovine serum albumin; Methotrexate; Solid lipid nanoparticles; Tumor targeting

Indexed keywords

ANTICANCER DRUG; BIPHASIC; BLOOD-BRAIN BARRIER; BRAIN CANCER; BRAIN CAPILLARY ENDOTHELIAL CELLS; BRAIN DELIVERY; CATIONIC BOVINE SERUM ALBUMIN; CATIONIC BOVINE SERUM ALBUMINS; CATIONIZED; CYTOTOXIC EFFECTS; IN-VITRO; METHOTREXATE; POTENTIAL ANALYSIS; RAPID RELEASE; SOLID LIPID NANOPARTICLES; SUSTAINED RELEASE; THERAPEUTIC EFFICACY; TRANSCYTOSIS; TUMOR CELLS; TUMOR TARGETING;

BODY FLUIDS; CELL CULTURE; CHEMOTHERAPY; CYTOTOXICITY; DISEASES; FOURIER TRANSFORM INFRARED SPECTROSCOPY; FOURIER TRANSFORMS; NANOPARTICLES; TRANSMISSION ELECTRON MICROSCOPY; TUMORS;

ENDOTHELIAL CELLS;

BOVINE SERUM ALBUMIN; METHOTREXATE; NANOCARRIER; SOLID LIPID NANOPARTICLE; SOLID LIPID NANOPARTICLE METHOTREXATE CONJUGATE; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; CANCER CELL CULTURE; CAPILLARY ENDOTHELIUM; CYTOTOXICITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; GLIA CELL; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; PARTICLE SIZE; PRIORITY JOURNAL; TRANSCYTOSIS; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

BOVINAE;

EID: 79551668385     PISSN: 15734137     EISSN: None     Source Type: Journal    
DOI: 10.2174/157341311794480291     Document Type: Article

References (46)

1. Kreuter, J. Nanoparticles. In: Kreuter, J., Ed. Colloidal Drug Delivery Systems. Marcel Dekker: New York, 1994, pp. 219-242.
2. Agarwal, A; Lariya, N.; Saraogi, G.; Dubey, N.; Agrawal, H.; Agrawal, G.P. Nanoparticles as novel carrier for brain delivery: a review. Cur. Pharm. Des., 2009, 15, 917-925.
3. Pardridge, W.M. Blood-brain barrier drug targeting: the future of brain drug development. Mol. Interv., 2003, 3, 90-105.
4. Begley, D. In: Sharma, H.S.; Westman, J., (Eds.), Blood, Spinal Cord and Brain Barriers in Health and Disease, Elsevier Science: Burlington, USA, 2003, pp. 83-97.
5. Schinkel, A.H. P-glycoprotein, a gatekeeper in the blood-brain barrier. Adv. Drug Deliv. Rev., 1999, 36, 179-194.
6. Tsuji, A. Tamai, I. Blood-brain barrier function of P-glycoprotein. Adv. Drug Deliv. Rev., 1997, 25, 287-298.
7. Carmeliet, P.; Jain, R.K. Angiogenesis in cancer and other diseases. Nature, 2000, 407, 249-257.
8. Gjini, E. Tumor angiogenesis; a review on established and innovative concepts in anti-angiogenic therapy. MSc. thesis, Faculty of Pharma Sci, Utrecht, 2005, pp. 1-56.
9. Arspe, M.L.I. The cell biology of angiogenesis. Angiogenesis, 2005, 1-30.
10. Agarwal, A.; Asthana, A.; Gupta, U.; Jain, N.K. Tumour and dendrimers: a review on drug delivery aspects. J. Pharm. Pharmacol., 2008, 60, 671-688.
11. Peppas, L.B.; Blanchette, J.O. Nanoparticles and targeted systems for cancer therapy. Adv. Drug Deliv. Rev., 2004, 56, 1649-1659.
12. Kabanov, A.V.; Chekhonin, V.P.; Alakhov, V.; Batrakova, E.V; Lebedev, A.S.; Melik-Nubarov, N.S.; Arzhakov, S.A.; Levashov, A.V.; Morozov, G.V.; Severin, E.S. The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles. Micelles as microcontainers for drug targeting. FEBS Lett., 1989, 258, 343-345.
13. Kohler, N.; Sun, C.; Fichtenholtz, A.; Gunn, J.; Fang, C.; Zhang, M. Methotrexate-Immobilized Poly(ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery. Small, 2006, 2(6), 785-792.
14. Chen, Y.H.; Tsai, C.Y.; Huang, P.Y.; Chang, M.Y.; Cheng, P.C.; Chou, C.H.; Chen, D.H.; Wang, C.R.; Shiau, A.L; Wu, C.L. Methotrexate Conjugated to Gold Nanoparticles Inhibits Tumor Growth in a Syngeneic Lung Tumor Model. Mol. Pharm., 2007, 4(5), 713-722.
15. Kohler, N.; Sun, C.; Fichtenholtz, A.; Gunn, J.; Fang, C.; Zhang, M.; Kukowska-Latallo, J.F.; Candido, K.A. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res., 2005, 65(12), 5317-5324.
16. Marttin, E.; Verhoef, J.C.; Spies F.; van der Meulen, J.; Nagelkerke, J.F.; Koerten H.K; Merkus, F.W. The effect of methylated beta-cyclodextrins on the tight junctions of the rat nasal respiratory epithelium: electron microscopic and confocal laser scanning microscopic visualization studies. J. Control. Release, 1999, 57, 205-213.
17. Wang, F.; Jiang, X.; Lu, W. Intranasal delivery of methotrexate to the brain in rats bypassing the blood-brain barrier. Drug Deliv. Technol., 2004, 4(1).
18. Muller, R.H.; Olbrich, C. Solid lipid nanoparticles: Phagocytic uptake, in vitro cytotoxicity and in vitro biodegradation. Drugs Made Ger., 1999, 42, 49-53.
19. Reddy, L.H.; Sharma, R.K.; Chuttani, K.; Mishra, A.K.; Murthy, R.R. Etoposide-incorporated tripalmitin nanoparticles with different surface charge: formulation, characterization, radiolabeling, and biodistribution studies. AAPS, 2004, 6(3), 1-10.
20. Muller, R.H.; Ruhl, D.; Runge, S.; Schulze-Foster, K.; Mehnert, W. Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant. Pharm. Res., 1997, 14, 458-462.
21. Muller, R.H.; Maassen, S.; Weyhers, H.; Mehnert, W. Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with Poloxamine 908 and Poloxamer 407. J. Drug Target., 1996, 4, 161-170.
22. Magenheim, B.; Levy, M.Y.; Benita, S. A new in vitro technique for evaluation of drug release profile from colloidal carriers-ultrafiltration technique at low pressure. Int. J. Pharm., 1993, 94, 115-123.
23. Utreja, S.; Jain, N.K. Solid lipid nanoparticles. In: Jain, N.K., Ed. Advances in controlled and novel drug delivery. CBS Publishers; New Delhi, India 2001, pp. 408-425.
24. Pople, P.V.; Singh, K.K. Development and evaluation of topical formulation containing solid lipid nanoparticles of vitamin A. AAPS PharmSci Tech., 2006, 7(4), E1-E7.
25. Nimje, N.; Agarwal, A.; Saraogi, G.K.; Lariya, N.; Rai, G.; Agrawal, H.; Agrawal, G.P. Mannosylated nanoparticulate carriers of rifabutin for alveolar targeting. J. Drug Target., 2009, 17(10), 777-787.
26. Wolf de, F.A.; Brett, G.M. Ligand-binding proteins, their potential for application in systems for controlled delivery and uptake of ligands. Pharmacol. Rev., 2000, 52, 207-236.
27. Molema, G. Design of vascular endothelium-specific drug-targeting strategies for the treatment of cancer. Acta Biochim. Pol., 2005, 52, 301-310.
28. Curnis, F.; Sacchi, A.; Corti, A. Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration. J. Clin. Invest., 2002, 18, 475-482.
29. Olson, T.A.; Mohanraj, D.; Roy, S.; Ramakrishnan, S. Targeting the tumor vasculature: inhibition of tumor growth by a vascular endothelial growth factor-toxin conjugate. Int. J. Cancer, 1997, 73, 865-870.
30. Zurita, A.J.; Arap, W.; Pasqualini, R. Mapping tumor vascular diversity by screening phage display libraries. J. Control. Release, 2003, 91, 183-186.
31. Kumagai, A.K.; Eisenberg, J.; Pardridge, W.M. Absorptive- mediated endocytosis of cationized albumin and a b-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. Model system of blood-brain barrier transport. J. Biol. Chem., 1987, 262, 15214-15219.
32. Triguero, D.; Buciak, J.B.; Pardridge, W.M. Capillary depletion method for quantifying blood-brain barrier transcytosis of circulating peptides and plasma proteins. J. Neurochem., 1990, 54, 1882-1888.
33. Thole, M.; Nobmann, S.; Huwyler, J.; Bartmann, A.; Fricker, G. Uptake of cationized albumin coupled liposomes by cultured porcine brain microvesselendothelial cells and intact brain capillaries. J. Drug Target., 2002, 10, 337-344.
34. Lu, W.; Tan, Y.Z.; Hu, K.L.; Jiang, X.G. Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier. Int. J. Pharm., 2005, 295, 247-260.
35. Bickel, U.; Yoshikawa, T.; Pardridge, W.M. Delivery of peptides and proteins through the blood-brain barrier. Adv. Drug Deliv. Rev., 2001, 46, 247-279.
36. Kim, K.J.; Byun, Y. Preparation and characterization of self-assembled pegylated gelatin nanoparticles. Biotechnol. Bioprocess Eng., 1999, 4, 210-214.
37. Aboleneen, H.; Simpson, J.; Backes, D. Determination of methotrexate in serum by high-performance liquid chromatography. J. Chromatogr. B, 1996, 681, 317-322.
38. Bhadra, D.; Bhadra, S.; Jain, S.; Jain, N.K. PEGylated dendritic nanoparticulate carrier of fluorouracil. Int. J. Pharm., 2003, 257, 111-124.
39. Kratzer, I.; Wernig, K.; Panzenboeck, U.; Bernhart, E.; Reicher, H.; Wronski, R.; Windisch, M.; Hammer, A.; Malle, E.; Zimmer, A.; Sattler, W. Apolipoprotein A-I coating of protamine-oligonucleotide nanoparticles increases particle uptake and transcytosis in an in vitro model of the blood-brain barrier. J. Control. Release, 2007, 117, 301-311.
40. Huang, M.; Ma, Z.; Khor, E.; Lim, L.Y. Uptake of FITC-chitosan nanoparticles by A549 cells. Pharm. Res., 2002, 19, 1488-1494.
41. Kolhe, P.; Misra, E.; Kannan, R.M.; Kannan, S.; Lieh-Lai, M. Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers. Int. J. Pharm., 2003, 259, 143-160.
42. Agrawal, P.; Gupta, U.; Jain, N.K. Glycoconjugated peptide dendrimersbased nanoparticulate system for the delivery of chloroquine phosphate. Biomaterials, 2007, 28, 3349-3359.
43. Kong, G.; Braun, R.D.; Dewhirst, M.W. Hyperthermia enables tumor specific nanoparticle delivery: Effect of particle size. Cancer Res., 2001, 60, 4440-4445.
44. Kumar P.V.; Asthana, A.; Dutta, T.; Jain, N.K. Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers. J. Drug Target., 2006, 14, 546-556.
45. Danhier, F.; Lecouturier, N.; Vroman, B.; Jérôme, C.; Marchand-Brynaert, J.; Feron, O.; Préat, V. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation. J. Control. Release, 2009, 133, 11-17.
46. Agarwal, A.; Gupta, U.; Asthana, A.; Jain, N.K. Dextran conjugated dendritic nanoconstructs as potential vectors for anti-cancer agent. Biomaterials, 2009, 30, 3588-3596.